Publications
8 publications
Funding
4 grants
Active
3 grants- KPR01AI192524-01Understanding resistance and tolerance to nitroimidazoles in Mycobacterium tuberculosisNational Institute of Allergy and Infectious Diseases · 2025–2029
- KPBMGF INV-055894Gene inactivation and modulation of Mtb targets to build combinationsBill & Melinda Gates Foundation · 2023–2026
- KPBMGF INV-055896Conditional Mtb knockdown mutants for TB drug discoveryBill & Melinda Gates Foundation · 2023–2026
Completed grants (1)
- KPINV-004764Partial gene inactivation and pharmacological modulation of Mtb targets (INV-004764)Bill & Melinda Gates Foundation · 2020–2023